Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Annika Allen has a challenging eco job: She’s helping CSL achieve its sustainability targets by encouraging suppliers to redu…
Visit Flu.com, sponsored by CSL Seqirus, to stay up to date on flu activity in the Northern Hemisphere and get answers to que…
U.S. patient organizations have until October 31 to apply for CSL Behring’s Local Empowerment for Advocacy Development (LEAD)…
CSL’s Debbie Drane recently spoke on a panel about how to keep momentum going following a record-setting year for cell and ge…
Raveen Milgelratne, part of CSL’s Australian Graduate Program, says that serving in Finance means helping patients by ensurin…
A team of CSL cyclists rode through the storm as Ophelia soaked Cape Cod.
Managing a rare disease takes time, but don’t let it crowd out social connections and spending time with friends and family.
Distrust of the health care system and provider bias can be addressed with a concerted effort to communicate how modern clini…
The National Organization for Rare Disorders is taking applications from patient organizations to establish two new patient r…
Americas
Asia Pacific
Middle East
Europe
